Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Genocea Biosciences, Inc. (GNCA)  
$0.59 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 51,640,000
Market Cap: 30.69(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.5943 - $0.5943
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Genocea Biosciences is a biopharmaceutical company that discovers and develops cancer immunotherapies using its proprietary ATLAS™ platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by sequencing of that patient's tumor. GEN-011 is an investigational solid tumor cell therapy candidate comprised of CD4+ and CD8+ neoantigen-targeted peripheral T cells. GEN-011 is comprised of T cells extracted from the patient's peripheral blood and specific for ATLAS-prioritized neoantigens. GEN-009 is an investigational neoantigen vaccine delivering adjuvanted synthetic long peptides from ATLAS-identified neoantigens.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 93,582,981
Total Sell Value $0 $0 $0 $6,768,648
Total People Sold 0 0 0 15
Total Sell Transactions 0 0 0 27
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 182
  Page 5 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Makhzoumi Mohamad 10% Owner   –       –       •   2019-02-14 4 B $0.47 $4,688,619 I/I 9,948,269 34,948,269 1.5     -
   Florence Anthony A. Jr. 10% Owner   –       –       •   2019-02-14 4 B $0.47 $4,688,619 I/I 9,948,269 34,948,269 1.5     -
   Barris Peter J 10% Owner   –       –       •   2019-02-14 4 B $0.47 $4,688,619 I/I 9,948,269 34,948,269 1.5     -
   Alfieri Michael Principle Financial Officer   •       –      –    2018-09-13 4 B $0.54 $5,400 D/D 10,000 10,000 2.74     -
   Siber George Director   –       •      –    2018-09-07 4 B $0.61 $8,174 D/D 13,400 165,417 2.39     -
   Siber George Director   –       •      –    2018-09-06 4 B $0.61 $15,250 D/D 25,000 152,017 2.39     -
   Siber George Director   –       •      –    2018-09-05 4 B $0.62 $15,500 D/D 25,000 127,017 2.39     -
   Siber George Director   –       •      –    2018-09-04 4 B $0.62 $15,500 D/D 25,000 102,017 2.39     -
   Siber George Director   –       •      –    2018-08-31 4 B $0.61 $15,250 D/D 25,000 77,017 2.39     -
   Siber George Director   –       •      –    2018-08-30 4 B $0.61 $15,250 D/D 25,000 52,017 2.39     -
   Siber George Director   –       •      –    2018-08-29 4 B $0.61 $15,250 D/D 25,000 27,017 2.39     -
   Clark William D President and CEO   •       •      –    2018-01-17 4 B $0.80 $20,000 D/D 25,000 82,931 2.81     -
   Poole Jonathan Chief Financial Officer   •       –      –    2017-07-24 4 AS $6.00 $270,000 D/D (45,000) 39,247     -
   Poole Jonathan Chief Financial Officer   •       –      –    2017-07-24 4 OE $3.09 $139,050 D/D 45,000 84,247     -
   Siber George Director   –       •      –    2017-05-19 4 S $6.07 $135,282 D/D (22,287) 2,017     -
   Siber George Director   –       •      –    2017-05-19 4 OE $2.38 $58,350 D/D 22,287 24,304     -
   Siber George Director   –       •      –    2017-05-18 4 S $6.02 $186,891 D/D (31,045) 2,017     -
   Siber George Director   –       •      –    2017-05-18 4 OE $1.67 $66,727 D/D 31,045 33,062     -
   Poole Jonathan Chief Financial Officer   •       –      –    2017-05-10 4 D $6.13 $21,455 D/D (3,500) 39,247     -
   Poole Jonathan Chief Financial Officer   •       –      –    2017-05-08 4 S $6.51 $40,447 D/D (6,213) 42,747     -
   Poole Jonathan Chief Financial Officer   •       –      –    2017-05-03 4 A $0.00 $0 D/D 31,747 48,960     -
   Hetherington Seth V Chief Medical Officer   •       –      –    2016-11-09 4 OE $2.02 $10,100 D/D 5,000 26,000     -
   Hoffman Eric S Chief Business Officer   •       –      –    2016-11-08 4 B $3.59 $10,770 D/D 3,000 11,790 2.74     -
   Poole Jonathan Chief Financial Officer   •       –      –    2016-11-07 4 B $3.34 $23,380 D/D 7,000 17,213 2.74     -
   Hoffman Eric S Chief Business Officer   •       –      –    2016-11-07 4 B $3.41 $13,640 D/D 4,000 8,790 2.74     -

  182 Records found
  1  2  3  4  5  6  7  8   
  Page 5 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed